Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jane N Winter

Showing results (21-30 of 142) with videos related to

Pageof 15
Sort By:
Current Stem Cell Research & Therapy|January 29, 2008
Use of radioimmunotherapy in stem cell transplantation and posttransplantation: focus on yttrium 90 ibritumomab tiuxetanArturo Molina, Amrita Krishnan, Henry Fung, et al.
Leukemia Research|April 8, 2004
Multiple unrelated clonal abnormalities in host bone marrow cells after allogeneic stem cell transplantationPartow Kebriaei, Jane N Winter, Ginna G Laport, et al.
Leukemia & Lymphoma|February 5, 2015
Strong expression of EZH2 and accumulation of trimethylated H3K27 in diffuse large B-cell lymphoma independent of cell of origin and EZH2 codon 641 mutationZheng Zhou, Juehua Gao, Relja Popovic, et al.
Cancer|June 19, 2009
Vincristine sulfate liposomes injection (Marqibo) in heavily pretreated patients with refractory aggressive non-Hodgkin lymphoma: report of the pivotal phase 2 studyM A Rodriguez, Robert Pytlik, Tomas Kozak, et al.
American Journal of Clinical Pathology|July 16, 2011
Clinical, morphologic, immunophenotypic, and molecular cytogenetic assessment of CD4-/CD8-γδ T-cell large granular lymphocytic leukemiaYi-Hua Chen, Amy Chadburn, Andrew M Evens, et al.
Leukemia & Lymphoma|April 25, 2007
Lack of an association between Chlamydia psittaci and ocular adnexal lymphomaGrace S Zhang, Jane N Winter, Daina Variakojis, et al.
Ejhaem|February 23, 2023
Phase I study of novel SYK inhibitor TAK-659 (mivavotinib) in combination with R-CHOP for front-line treatment of high-risk diffuse large B-cell lymphomaReem Karmali, Frederique St-Pierre, Shuo Ma, et al.
British Journal of Haematology|April 26, 2014
Frontline bortezomib and rituximab for the treatment of newly diagnosed high tumour burden indolent non-Hodgkin lymphoma: a multicentre phase II studyAndrew M Evens, Mitchell R Smith, Izidore S Lossos, et al.
Cardio-Oncology (London, England)|November 8, 2025
Longitudinal echocardiographic monitoring and cardiovascular outcomes in adult survivors of childhood cancerEli Grunblatt, Ian K Everitt, Karen Kinahan, et al.
Value in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research|April 19, 2026
Validation and Clinical Meaningfulness of the 18-item National Comprehensive Cancer Network-Functional Assessment of Cancer Therapy (NCCN-FACT) Lymphoma Symptom Index (NFLymSI-18) in Patients with LymphomaKimberly A Webster, Anne R Zola, Maria Corona, et al.
Pageof 15

Showing results (21-30 of 142) with videos related to

Sort By:
Pageof 15
Current Stem Cell Research & Therapy|January 29, 2008
Use of radioimmunotherapy in stem cell transplantation and posttransplantation: focus on yttrium 90 ibritumomab tiuxetanArturo Molina, Amrita Krishnan, Henry Fung, et al.
Leukemia Research|April 8, 2004
Multiple unrelated clonal abnormalities in host bone marrow cells after allogeneic stem cell transplantationPartow Kebriaei, Jane N Winter, Ginna G Laport, et al.
Leukemia & Lymphoma|February 5, 2015
Strong expression of EZH2 and accumulation of trimethylated H3K27 in diffuse large B-cell lymphoma independent of cell of origin and EZH2 codon 641 mutationZheng Zhou, Juehua Gao, Relja Popovic, et al.
Cancer|June 19, 2009
Vincristine sulfate liposomes injection (Marqibo) in heavily pretreated patients with refractory aggressive non-Hodgkin lymphoma: report of the pivotal phase 2 studyM A Rodriguez, Robert Pytlik, Tomas Kozak, et al.
American Journal of Clinical Pathology|July 16, 2011
Clinical, morphologic, immunophenotypic, and molecular cytogenetic assessment of CD4-/CD8-γδ T-cell large granular lymphocytic leukemiaYi-Hua Chen, Amy Chadburn, Andrew M Evens, et al.
Leukemia & Lymphoma|April 25, 2007
Lack of an association between Chlamydia psittaci and ocular adnexal lymphomaGrace S Zhang, Jane N Winter, Daina Variakojis, et al.
Ejhaem|February 23, 2023
Phase I study of novel SYK inhibitor TAK-659 (mivavotinib) in combination with R-CHOP for front-line treatment of high-risk diffuse large B-cell lymphomaReem Karmali, Frederique St-Pierre, Shuo Ma, et al.
British Journal of Haematology|April 26, 2014
Frontline bortezomib and rituximab for the treatment of newly diagnosed high tumour burden indolent non-Hodgkin lymphoma: a multicentre phase II studyAndrew M Evens, Mitchell R Smith, Izidore S Lossos, et al.
Cardio-Oncology (London, England)|November 8, 2025
Longitudinal echocardiographic monitoring and cardiovascular outcomes in adult survivors of childhood cancerEli Grunblatt, Ian K Everitt, Karen Kinahan, et al.
Value in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research|April 19, 2026
Validation and Clinical Meaningfulness of the 18-item National Comprehensive Cancer Network-Functional Assessment of Cancer Therapy (NCCN-FACT) Lymphoma Symptom Index (NFLymSI-18) in Patients with LymphomaKimberly A Webster, Anne R Zola, Maria Corona, et al.
Pageof 15